Who we are
Life science is always asking new questions.
It's essential to the discovery process.
As Life Science moves forward, more and more innovative tools and techniques emerge that will change the field of life science and healthcare. Someone has to provide stable and reliable solutions for identifying the right techniques and generating solid data from them. That's where we come in.
Svar Life Science, a Swedish group of companies, specializes in inventing, developing, and applying the best assay technology for drug development and clinical diagnostics. We aim to deliver tailored solutions, create practical platforms for routine clinical testing, and share knowledge to enhance competencies through partnerships.
You can be sure of our answers
We work to deliver the right answers at the right time to improve patient care and accelerate drug development. With over 30 years of experience in the clinical diagnostic value chain, we excel in autoimmunity, inflammatory diseases, and oncology, offering customized cell-based and immunoassays for biopharma companies and clinical labs worldwide.
We cover the entire drug development value chain, from discovery to clinical phases, and provide tools for effective patient diagnosis and monitoring. By pushing boundaries in drug discovery and diagnostics, we contribute to better patient care.
Svar means answers in Swedish.
We're here to help you find the right answers to your questions.
Ask us today!
A Legacy of Innovation and Excellence
For nearly three decades, Svar Life Science has been working with assay solution development for the global life science market. Rooted in a strong Scandinavian heritage, we are dedicated to delivering high-quality, responsive services. Innovation, strategic partnerships, and a relentless pursuit of optimal solutions for patient care and drug development characterize our journey.
In 2018, Euro Diagnostica transformed into Svar Life Science, signifying our commitment to answers and our position as a key player in the dynamic life science sector.
Key milestones include joining forces with Calpro AS in 2017, expanding horizons with the 2014 acquisition of Biomonitor A/S, and enhancing expertise through the 2011 acquisition of Vita Diagnostika GmbH.
Throughout our history, milestones like the 2007 introduction of the CCPoint assay and the groundbreaking 2002 Anti-CCP2 assay have marked our dedication to revolutionizing diagnostics. Our journey began in 1992, offering assay solutions and evolving to serve the life science community while staying true to our Scandinavian heritage.
Today, Svar Life Science is a testament to our dedication to advancing healthcare through cutting-edge solutions and collaborative partnerships.
We strongly believe that the sharing of knowledge, skills, and networks is not only a key driver for innovation but the key to pioneering new solutions and finding new partnering opportunities.
As a company that values innovation, we always seek new and exciting ideas and solutions for drug development and clinical diagnostics. We would love to hear from you!